Submitted on Thursday 8th December 2016
Published on Thursday 15th December 2016
Current status: Closed
Closed: Tuesday 2nd May 2017
Signatures: 1,336
Ensure the Pfizer and Flynn Pharma CMA fines are used solely to improve NHS care
Pharmaceutical companies Pfizer and Flynn Pharma have been fined a total of £89.4m by the Competition and Marketing Authority for exploiting a monopoly position over the marketing of the epilepsy drug Epanutin. Their actions have cost the NHS an estimated £44m per year for the last 4 years.
The cost of this scandal has been entirely born by the NHS, and if all the fines are returned to the NHS it will still fall short of the £176m extra the NHS has had to pay for this vital drug. Patients with epilepsy have been most affected, and so some of the money should be used to employ Epilepsy Nurses to improve epilepsy care. See https://binscombedoctorblog.wordpress.com/2012/10/06/the-marketing-of-epanutin-re-energising-a-product-for-an-underserved-population-or-big-pharma-behaving-badly/
You can't sign this petition because it is now closed. But you can still comment on it here at Repetition.me!
3.138.204.208 Thu, 02 May 2024 13:01:59 +0100
